HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goddu, S.M. Articles by Rao, D. V. Search for Related Content PubMed PubMed Citation Articles by Goddu, S.M. Articles by Rao, D. V.

Biological Dosimetry of Bone Marrow for Incorporated Yttrium-90

Departments of Radiology and Pathology, UMDNJ-New Jersey Medical School, Newark, New Jersey

Correspondence: For correspondence or reprints contact: Dandamudi V. Rao, PhD, Professor of Radiology, UMDNJ-New Jersey Medical School, MSB F-451A, 185 South Orange Ave., Newark, NJ 07103.

ABSTRACT

The biological response of bone marrow to incorporated radionuclides depends on several factors such as absorbed dose, dose rate, proliferation and marrow reserve. The determination of the dose rate and absorbed dose to bone marrow from incorporated radionuclides is complex. This research used survival of granulocyte-macrophage colony-forming cells (GM-CFCs) as a biological dosimeter to determine experimentally the dose rate and dose to bone marrow after administration of ⁹⁰Y-citrate. Methods: The radiochemical ⁹⁰Y-citrate was administered intravenously to Swiss Webster mice. Biokinetics studies indicated that the injected ⁹⁰Y quickly localized in the femurs (0.8%ID/femur) and cleared with an effective half-time of 62 hr. Subsequently, GM-CFC survival was determined as a function of femur uptake and injected activity. Finally, to calibrate GM-CFC survival as a biological dosimeter, mice were irradiated with external ¹³⁷Cs gamma rays at dose rates that decreased exponentially with a half-time of 62 hr. Results: Femur uptake was linearly proportional to injected activity. The survival of GM-CFCs was exponentially dependent on both the initial ⁹⁰Y femur activity and the initial dose rate from external ¹³⁷Cs gamma rays with 5.1 kBq/femur and 1.9 cGy/hr, respectively, required to achieve 37% survival. Thus, ⁹⁰Y-citrate delivers a dose rate of 0.37 cGy/hr to the femoral marrow per kBq of femur activity and the dose rate decreased with an effective half-time of 62 hr. Conclusion: Survival of GM-CFCs can serve as a biological dosimeter to experimentally determine the dose rate kinetics in bone marrow.

Key Words: radionuclide therapy • biological dosimetry • bone marrow • dose rate

This article has been cited by other articles:

				G. Sgouros Dosimetry of Internal Emitters J. Nucl. Med., January 1, 2005; 46(1_suppl): 18S - 27S. [Abstract] [Full Text] [PDF]

				N. F. MARKO, P. B. DIEFFENBACH, G. YAN, S. CERYAK, R. W. HOWELL, T. A. MCCAFFREY, and V. W. HU Does metabolic radiolabeling stimulate the stress response? Gene expression profiling reveals differential cellular responses to internal beta vs. external gamma radiation FASEB J, August 1, 2003; 17(11): 1470 - 1486. [Abstract] [Full Text] [PDF]

				G. Bussolati, M. Chinol, B. Chini, A. Nacca, P. Cassoni, and G. Paganelli 111In-labeled 1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic Acid-Lys8-Vasotocin: A New Powerful Radioligand for Oxytocin Receptor-expressing Tumors Cancer Res., June 1, 2001; 61(11): 4393 - 4397. [Abstract] [Full Text] [PDF]

				M. Lenarczyk, S. M. Goddu, D. V. Rao, and R. W. Howell Biologic Dosimetry of Bone Marrow: Induction of Micronuclei in Reticulocytes After Exposure to 32P and 90Y J. Nucl. Med., January 1, 2001; 42(1): 162 - 169. [Abstract] [Full Text] [PDF]

				A. Bishayee, D. V. Rao, S. C. Srivastava, L. G. Bouchet, W. E. Bolch, and R. W. Howell Marrow-Sparing Effects of 117mSn(4+)Diethylenetriaminepentaacetic Acid for Radionuclide Therapy of Bone Cancer J. Nucl. Med., December 1, 2000; 41(12): 2043 - 2050. [Abstract] [Full Text] [PDF]